Abstract:Chemotherapy utilizing cytotoxic drugs such as paclitaxel (PTX) is still a major therapeutic approach to treat both localized and metastasized cancers. Unlike traditional regimens, where PTX is administered at the maximum tolerated dose, alternative regimen like metronomic dosing are proving beneficial, where PTX is administered more frequently and in much lower doses exploring anti-angiogenic and immunomodulatory effects. However, PTX-induced peripheral neuropathy (PIPN) and lack of non-invasive dosage forms of PTX are major roadblocks for the successful implementation of metronomic regimens. Given the success of polyester nanoparticle drug delivery, our aim was to explore the potential of nanoparticle-encapsulated paclitaxel (nPTX) in alleviating PIPN in an experimental rat model. In this study, rats were injected intraperitoneal with 2 mg/kg body weight of PTX or nPTX on four alternate days and PIPN was characterized using behavioral assessments, histology and immunohistochemistry. PIPN was revealed by a significant decrease in the tactile sensitivity and pressure pain threshold in PTX group compared to the nPTX group over a 16-day study period. The behavior data was supported by histological assessments, where PTX group showed a higher degree of dorsal root ganglion (DRG) degeneration and a significant reduction in motor neurons compared to nPTX group. Further, immunofluorescence data reveals increase in the density of neuronal marker β-tubulin-III (TUBB3), reduced TUNEL positive cells and increase in high molecular weight neurofilament (NFH) in spinal cord, DRG and sciatic nerve for nPTX group. Therefore, this work has important implications in improving risk-benefit profile of PTX, paving way for metronomic regimens. The characteristics of nPTX used in this present study. a) Table showing the formulation characteristics of different batches b) Representative dynamic light scattering particle size distribution profile and c) Representative scanning electron micrograph of nPTX. *The difference in the entrapment numbers is not the reproducibility issue, but different volume of the suspension used in the vial for freeze drying. nPTX reduces the pain hypersensitivity of rats compared to those treated with PTX. a) Tactile threshold and b) Pressure threshold, time course of the effect of intraperitoneal injections of PTX and nPTX at 2mg/kg administered as indicated by arrows on x-axis. BL is baseline data. We used same rats in a & b experiments. *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 comparisons were made between PTX vs nPTX; two-way analysis of variance followed by Tukey's multiple comparisons test (n=8). nPTX prevents dorsal root ganglion (DRG) degeneration. a) H&E-stained sections were prepared from the DRG nerve at the end of the study. b) PTX group showed degeneration of neurons presenting significantly low in DRG numbers compared to nPTX group indicated with bright red arrowheads. c) PTX levels in DRG, PTX and nPTX groups are not significant. ***p < 0.001 comparisons were made between PTX vs nPTX; two-way analysis of variance followed by Tukey's multiple comparisons test. nPTX increase motor neuron survival in spinal cord (SC) region. a) Representative images of ventral root horn spinal cords of PTX and nPTX treated rats. b) SC motor neuron counts significantly decreased in PTX groups compared to nPTX. Images were acquired at 10 and 40x original magnification. c) PTX levels in SC, PTX and nPTX groups are not significant. The PTX levels between DRG and SC are about 100 orders of magnitude, presumably due to the deficiency in blood-nerve barrier in the former. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Soluble Epoxide Hydrolase Inhibitor TPPU Alleviates Nab-Paclitaxel-Induced Peripheral Neuropathic Pain via Suppressing NF-kappa B Signalling in the Spinal Cord of a Rat

Soluble Epoxide Hydrolase Inhibitor TPPU Alleviates Nab-Paclitaxel-Induced Peripheral Neuropathic Pain via Suppressing NF- κ B Signalling in the Spinal Cord of a Rat

Delayed Inhibition of ERK and P38 Attenuates Neuropathic Pain Without Affecting Motor Function Recovery after Peripheral Nerve Injury.

Inhibition of Notch pathway Alleviates nab-Paclitaxel-Induced Peripheral Neuropathic Pain in Rats via Suppressing HMGB1/TLR4 Signaling in Spinal Cord

The soluble epoxide hydrolase inhibitor TPPU improves comorbidity of chronic pain and depression via the AHR and TSPO signaling

Polyester nanoparticle-encapsulated paclitaxel mitigates paclitaxel-induced peripheral neuropathy

The Beneficial Effects of Heme Oxygenase 1 and Hydrogen Sulfide Activation in the Management of Neuropathic Pain, Anxiety- and Depressive-like Effects of Paclitaxel in Mice

Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway

Puerarin suppresses TRPV1, calcitonin gene-related peptide and substance P to prevent paclitaxel-induced peripheral neuropathic pain in rats

Schwann Cell-Derived Exosomes Ameliorate Paclitaxel-Induced Peripheral Neuropathy Through the miR-21-Mediated PTEN Signaling Pathway

Attenuation of p38 MAPK/NF‐κB/TRPV1/CGRP is involved in the antinociceptive effect of hesperidin methyl chalcone and taxifolin in paclitaxel‐induced peripheral neuropathy

Roles of Thermosensitive Transient Receptor Channels TRPV1 and TRPM8 in Paclitaxel-Induced Peripheral Neuropathic Pain

EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model

Sodium Aescinate Alleviates Neuropathic Pain in Rats by Suppressing the TLR4/NF KB Pathway Activation after Paclitaxel Chemotherapy

Amelioration of Neuropathic Pain and Attenuation of Neuroinflammation Responses by Tetrahydropalmatine Through the p38MAPK/NF-κB/iNOS Signaling Pathways in Animal and Cellular Models

Phosphate NIMA-Related Kinase 2-Dependent Epigenetic Pathways in Dorsal Root Ganglion Neurons Mediates Paclitaxel-Induced Neuropathic Pain

Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain

Ursolic acid alleviates paclitaxel-induced peripheral neuropathy through PPARγ activation

Paclitaxel Inhibits KCNQ Channels in Primary Sensory Neurons to Initiate the Development of Painful Peripheral Neuropathy

PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway

Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1α pathway